Inclusion Criteria:  Aged between 40-60 years old; Scoring 14 points or more in at least one day during the one-week baseline assessment, or having an average of ≥ 7 moderate or severe heating per 24 hours recorded in HF Dairy ;  Fulfilling either condition mentioned below:  The last menstrual period was more than 12 months ago (including 12 months); In the late menopausal transition, and has amenorrhea for more than 60 days; FSH≥25IU, and has vasomotor symptoms of HF, sweating, insomnia, migraine, or restlessness, etc. Volunteer to participate in this study and sign the informed consent.  Exclusion Criteria:  Usage of HRT via transdermal administration in the previous one month, or via oral or intrauterine administration in the previous two months; usage of phytoestrogens therapy, transvaginal estrogen administration, or estrogen or progesterone injections in the previous three months; Bilateral salpingo-oophorectomy; Amenorrhea secondary to premature ovarian failure, ovarian cyst or tumor, thyroid disease, hyperprolactinemia, or Cushing's syndrome, etc.; Accepted acupuncture or drugs to treat the symptoms of HF within the previous 3 months; Received radiotherapy or chemotherapy before; Coagulation dysfunction, or taking warfarin, heparin and other anticoagulant drugs at present; Suffering from skin diseases, such as eczema, psoriasis, etc.; Severe hepatic and renal insufficiency; Uncontrolled hypertension, diabetes or thyroid disease; Diabetic neuropathy and mental illness (including depression); Being pregnant, breastfeeding or planning to be pregnant during the trial; Regular usage of sedatives or anti-anxiety drugs; Smoking for more than 5 years (at least twenty cigarettes a day on average) , or with the problem of alcohol abuse; Installation of pacemakers; Poor compliance.